|
PRPF40A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.195200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.359600E-03 |
| Normal-vs-Stage2 |
2.696900E-03 |
| Normal-vs-Stage3 |
3.964900E-04 |
| Normal-vs-Stage4 |
7.663800E-03 |
| Stage1-vs-Stage2 |
4.846200E-01 |
| Stage1-vs-Stage3 |
3.586800E-01 |
| Stage1-vs-Stage4 |
8.535600E-01 |
| Stage2-vs-Stage3 |
9.776600E-01 |
| Stage2-vs-Stage4 |
6.767400E-01 |
| Stage3-vs-Stage4 |
6.351800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.952500E-04 |
| Normal-vs-AfricanAmerican |
4.589600E-01 |
| Normal-vs-Asian |
3.661000E-03 |
| Caucasian-vs-AfricanAmerican |
1.269790E-01 |
| Caucasian-vs-Asian |
7.849000E-01 |
| AfricanAmerican-vs-Asian |
1.259800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.752000E-04 |
| Normal-vs-Female |
1.658130E-03 |
| Male-vs-Female |
3.536000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.266100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.582330E-04 |
| Normal-vs-Age(61-80Yrs) |
1.780720E-03 |
| Normal-vs-Age(81-100Yrs) |
4.523800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.345020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.096800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.251400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.639000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.483800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.308600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.675800E-01 |
| Classical-VS-Follicular |
2.041900E-03 |
| Classical-VS-Other |
1.071820E-01 |
| Classical-VS-Normal |
1.201520E-02 |
| Tall-VS-Follicular |
1.594780E-01 |
| Tall-VS-Other |
1.663220E-01 |
| Tall-VS-Normal |
2.964400E-02 |
| Follicular-VS-Other |
5.910400E-01 |
| Follicular-VS-Normal |
2.3695999999962E-05 |
| Other-VS-Normal |
6.739200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.009290E-04 |
| Normal-vs-N1 |
1.317710E-03 |
| N0-vs-N1 |
8.670000E-01 |
|
|
